5Daniel LB,Maisel AS.Natriuretic peptides[J].J Am Coll Cardiol,2007,50:2357-2368.
6Vardeny O,Miller R,Solomon SD.Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure[J].JACC Heart Fail,2014,2:663-670.
7Macheret F,Heublein D,Costello-Boerrigter LC,et al.Human hypertension is characterized by a lack of activation of the anti-hypertensive cardiac hormones ANP and BNP[J].J Am Coll Cardiol,2011,57:1386-1395.
8Wang TJ,Larson MG,Levy D,et al.Impact of obesity on plasma natriuretic peptide levels[J].Circulation,2004,109:594-600.
9McKie PM,Cataliotti A,SangaraIingham SJ,et al.Predictive utility of atrial,N-terminal pro-atrial,and N-terminal pro-B-type natriuretic peptides for mortali- ty and cardiovascular events in the general community:a 9-year follow-up study[J].Mayo Clin Proc,2011,86:1154-1160.
10von Lueder TG,Krum H.RASS inhibitors and cardiovascular protection in large scale trials[J].Cardiovasc Drugs Ther,2013,27:171-179.
